About Thomas Fratacci
Form D filings for RheumaGen in 2024 list Thomas Fratacci as director.
Thomas Fratacci first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Fratacci in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thomas Fratacci works with at each company, as listed on that company's latest Form D.
RheumaGen, Inc. · Form D, Apr 17, 2024
RH
Ryan Hart
Chief Legal Officer
BM
Bobak Mozayeni
Executive officer
BG
Bruce Goodwin
Director
BF
Brian Freed
Executive officer
RI
Richard Freed, III
Executive officer and director
JJ
James Hart, Jr.
Executive officer